DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Claims 9-23 are canceled. Therefore, claims 1-8 are currently pending in this Application.
Priority
CONTINUING DATA
This application is a 371 of PCT/JP2021/027915 07/28/2021
FOREIGN APPLICATIONS
JAPAN 2020-128216 07/29/2020
Information Disclosure Statement
Applicant’s Information Disclosure Statements, filed on 02/25/2023; 10/14/2024; 06/02/2025; 11/12/2025; and 01/29/2026 have been considered. Please refer to Applicant’s copies of the 1449 submitted herewith.
Application Title
The title of the invention, i.e. “Method of Manufacturing Compound” is not descriptive. A new title is required that is clearly indicative of the invention to which the claims are directed. The following title is suggested: " Method of Manufacturing Pyrazolone Compounds ”
Response to Restriction
Applicants’ election, without traverse, the invention of Group I, claims 1-8, drawn to a method of preparing products of Formula 3,
PNG
media_image1.png
133
175
media_image1.png
Greyscale
, in response filed on April 16, 2026 is acknowledged.
Therefore, the restriction requirement is considered proper and is maintained.
Applicant is reminded that upon the cancellation of claims to a non-elected invention, the inventorship must be amended in compliance with 37 CFR 1.48(b) if one or more of the currently named inventors is no longer an inventor of at least one claim remaining in the application. Any amendment of inventorship must be accompanied by a petition under 37 CFR 1.48(b) and by the fee required under 37 CFR 1.17(i).
Claim Rejections - 35 USC § 102
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention.
(a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention.
Claims 1-8 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Dirat et al. Tetrahedron Letters 47 (2006) 1729–1731.
The instant elected invention is drawn to a process of preparing pyrazolone products of Formula 3,
PNG
media_image1.png
133
175
media_image1.png
Greyscale
wherein the variables are as defined in claim 1. The process comprises reacting a hydrazine product of Formula 1,
PNG
media_image2.png
84
156
media_image2.png
Greyscale
with acetoacetate product of Formula 2,
PNG
media_image3.png
78
192
media_image3.png
Greyscale
.
Claims 2-8 further define the variables R1, R2 and R3.
Dirat et al teach a process of preparing pyrozolone products by reaction a hydrazine product and an acetoacetate product ( See Scheme 2)
PNG
media_image4.png
94
246
media_image4.png
Greyscale
Therefore, claims 1-8 are anticipated by Dirat et al
Telephone Inquiry
Any inquiry concerning this communication or earlier communications from the examiner should be directed to KAMAL A SAEED whose telephone number is (571) 272-0705.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Adam C Milligan can be reached at (571)270-7674. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000
/Kamal A Saeed/
Primary Examiner, Art Unit 1626
Prosecution Insights